Takes an Important Step Towards the Start of its Clinical Trial to Evaluate the Analytical…
Live moderated video webcast on Wednesday, May 11th at 1:00 PM ET ISELIN, N.J., May…
LAWRENCEVILLE, N.J., May 09, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company…
Allogeneic CAR T Pioneer Highest Ranked Bay Area Biotech in the Large Company Category Based on…
Live conference call at 8:30 a.m. EST MIAMI, May 09, 2022 (GLOBE NEWSWIRE) — Longeveron…
SOUTH SAN FRANCISCO, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
Conference call and webcast to be held at 4:30 pm ET BOSTON, May 09, 2022…
Phase 3 DiSCOVER clinical trial initiation expected by end of Q2 2022 NEWTON, Mass., May…
Toxicology data published in the international peer-reviewed scientific journal “Toxicologic Pathology” demonstrates excellent safety profile…
SOMERVILLE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
CAMBRIDGE, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced that…
Digestive Disease Week is the largest international gathering of physicians, researchers and academics in the…
SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) — Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company…
ARLINGTON, Mass., May 09, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical…
COPENHAGEN, Denmark, May 09, 2022 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) announced today…
— First shipment of HAVs to six Ukrainian hospitals made today — — Product candidate…
SOUTH SAN FRANCISCO, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO),…
Immix Biopharma Announces Share Repurchase Program Immix Biopharma, Inc. (NASDAQ:IMMX) LOS ANGELES, May 09, 2022…
Consolidated Net Revenue of $11.9 Million Up 6% vs. First Quarter of 2021 U.S. Net…
Company enters into collaborations with leading next generation sequencing (NGS) companies to facilitate trial enrollment…